🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to observe patients being treated with...
Status
Completed
Location
Rheumatology Associates, PC
Start Date
2011-11-15
Trial ID
NCT01466166
Treatments Being Tested
The primary objective of this trial is to evaluate the effect of pegloticas...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-02-09
Trial ID
NCT07388498
Treatments Being Tested
This is a Phase 1 single dose study conducted to evaluate the PK and PD of ...
Status
Completed
Location
Davita Clinical Research
Start Date
2012-12
Trial ID
NCT01739660
Treatments Being Tested
The purpose of this study is to assess the potential for pegloticase with m...
Status
Completed
Location
University of Alabama
Start Date
2019-06-13
Trial ID
NCT03994731
The purpose of this study is to determine whether PEG-uricase (a chemically...
Status
Completed
Location
Duke University Medical Center
Start Date
2004-12
Trial ID
NCT00111657
Treatments Being Tested
Pegloticase treatment for chronic refractory gout is limited by immunogenic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-06-14
Trial ID
NCT03303989
Treatments Being Tested
The overall objective of the study is to assess the efficacy, safety, toler...
Status
Completed
Location
Orthopedic Physicians Alaska
Start Date
2018-09-26
Trial ID
NCT03635957
This is a randomized, open-label, multicenter, parallel-groups study of mul...
Status
Completed
Location
Spain Rehabilitation Center
Start Date
2004-03
Trial ID
NCT00080210
Treatments Being Tested
This trial is to assess efficacy, safety, blood levels and bodily effects o...
Status
Completed
Location
Orthopedic Physicians Alaska
Start Date
2021-01-26
Trial ID
NCT04762498
Treatments Being Tested
The study consists of 24-week double-blind trial to evaluate the non-inferi...
Status
Completed
Location
The University of Alabama at Birmingham (UAB)
Start Date
2024-03-18
Trial ID
NCT06229145
Treatments Being Tested